Stocks News

LAST PRICE
366.5400
TODAY'S CHANGE (%)
Trending Up1.5200 (0.4164%)

Bid / Lots
353.0100/ 1
Ask / Lots
413.1900/ 1
Open / Previous Close
366.5900 / 365.0200
Day Range
Low 364.0700
High 369.1700
52 Week Range
Low 310.4200
High 415.7300
Volume
332,532
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Apr 30, 2024
- West to Participate in Upcoming Investor Conference, from 6:00AM ET on Tuesday Apr 30, 2024 by PR Newswire
  6:00AM ET on Tuesday Apr 30, 2024 by PR Newswire
  Companies Mentioned: WST
  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Bank of America Securities Healthcare Conference in Las Vegas, NV on Tuesday, May 14, 2024, at 11:20 AM PT.
- West to Participate in Upcoming Investor Conference, from 6:00AM ET on Tuesday Apr 30, 2024 by Dow Jones
  6:00AM ET on Tuesday Apr 30, 2024 by Dow Jones
  Companies Mentioned: WST
  
  West to Participate in Upcoming Investor Conference
  
  PR Newswire
  
  EXTON, Pa., April 30, 2024
  
  EXTON, Pa., April 30, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Bank of America Securities Healthcare Conference in Las Vegas, NV on Tuesday, May 14, 2024, at 11:20 AM PT.
Apr 26, 2024
- UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating, from 11:34AM ET on Friday Apr 26, 2024 by MT Newswires
  11:34AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: WST
  11:34 AM EDT, 04/26/2024 (MT Newswires) -- West Pharmaceutical Services (WST) has an average rating of outperform and price targets ranging from $336 to $470, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and eco...
- Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423, from 10:56AM ET on Friday Apr 26, 2024 by MT Newswires
  10:56AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: WST
  10:56 AM EDT, 04/26/2024 (MT Newswires) -- West Pharmaceutical Services (WST) has an average outperform rating and a price target range of $336 to $470, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic ...
Apr 25, 2024
- West Pharmaceutical's Q1 Adjusted Earnings, Net Sales Fall; 2024 Adjusted EPS Outlook Raised, from 8:34AM ET on Thursday Apr 25, 2024 by MT Newswires
  8:34AM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: WST
  08:34 AM EDT, 04/25/2024 (MT Newswires) -- West Pharmaceutical Services (WST) reported Q1 adjusted earnings Thursday of $1.56 per diluted share, down from $1.98 a year earlier. Analysts polled by Capital IQ expected $1.29. Net sales for the quarter...

May 3, 2024
- Raymond James Adjusts Price Target on Zimmer Biomet Holdings to $138 From $142, from 11:17AM ET on Friday May 03, 2024 by MT Newswires
  11:17AM ET on Friday May 03, 2024 by MT Newswires
  Companies Mentioned: ZBH
- UBS Adjusts Price Target on Zimmer Biomet Holdings to $112 From $109, Maintains Sell Rating, from 11:07AM ET on Friday May 03, 2024 by MT Newswires
  11:07AM ET on Friday May 03, 2024 by MT Newswires
  Companies Mentioned: ZBH
- Truist Adjusts Zimmer Biomet Holdings' PT to $130 From $137, Keeps Hold Rating, from 9:53AM ET on Friday May 03, 2024 by MT Newswires
  9:53AM ET on Friday May 03, 2024 by MT Newswires
  Companies Mentioned: ZBH
- Bernstein Adjusts Price Target on Zimmer Biomet to $133 From $132, from 9:41AM ET on Friday May 03, 2024 by MT Newswires
  9:41AM ET on Friday May 03, 2024 by MT Newswires
  Companies Mentioned: ZBH
- Jefferies Adjusts Price Target on Zimmer Biomet to $135 From $136, from 8:31AM ET on Friday May 03, 2024 by MT Newswires
  8:31AM ET on Friday May 03, 2024 by MT Newswires
  Companies Mentioned: ZBH
- Citigroup Adjusts Price Target on Zimmer Biomet to $134 From $140, from 8:23AM ET on Friday May 03, 2024 by MT Newswires
  8:23AM ET on Friday May 03, 2024 by MT Newswires
  Companies Mentioned: ZBH
- Morgan Stanley Adjusts Price Target on Zimmer Biomet to $130 From $135, from 8:18AM ET on Friday May 03, 2024 by MT Newswires
  8:18AM ET on Friday May 03, 2024 by MT Newswires
  Companies Mentioned: ZBH
- Jefferies Adjusts Zimmer Biomet Price Target to $135 From $136, from 7:37AM ET on Friday May 03, 2024 by MT Newswires
  7:37AM ET on Friday May 03, 2024 by MT Newswires
  Companies Mentioned: ZBH
- Citigroup Adjusts Zimmer Biomet Price Target to $134 From $140, from 7:19AM ET on Friday May 03, 2024 by MT Newswires
  7:19AM ET on Friday May 03, 2024 by MT Newswires
  Companies Mentioned: ZBH
- Morgan Stanley Adjusts Zimmer Biomet Price Target to $130 From $135, from 7:08AM ET on Friday May 03, 2024 by MT Newswires
  7:08AM ET on Friday May 03, 2024 by MT Newswires
  Companies Mentioned: ZBH

West Pharmaceutical Services Inc
NYSE:WSTUnited States

Search Criteria

Apr 30, 2024

West to Participate in Upcoming Investor Conference, from 6:00AM ET on Tuesday Apr 30, 2024 by PR Newswire

West to Participate in Upcoming Investor Conference, from 6:00AM ET on Tuesday Apr 30, 2024 by Dow Jones

Apr 26, 2024

UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating, from 11:34AM ET on Friday Apr 26, 2024 by MT Newswires

Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423, from 10:56AM ET on Friday Apr 26, 2024 by MT Newswires

Apr 25, 2024

West Pharmaceutical's Q1 Adjusted Earnings, Net Sales Fall; 2024 Adjusted EPS Outlook Raised, from 8:34AM ET on Thursday Apr 25, 2024 by MT Newswires

Peers Headlines

May 3, 2024

Raymond James Adjusts Price Target on Zimmer Biomet Holdings to $138 From $142, from 11:17AM ET on Friday May 03, 2024 by MT Newswires

UBS Adjusts Price Target on Zimmer Biomet Holdings to $112 From $109, Maintains Sell Rating, from 11:07AM ET on Friday May 03, 2024 by MT Newswires

Truist Adjusts Zimmer Biomet Holdings' PT to $130 From $137, Keeps Hold Rating, from 9:53AM ET on Friday May 03, 2024 by MT Newswires

Bernstein Adjusts Price Target on Zimmer Biomet to $133 From $132, from 9:41AM ET on Friday May 03, 2024 by MT Newswires

Jefferies Adjusts Price Target on Zimmer Biomet to $135 From $136, from 8:31AM ET on Friday May 03, 2024 by MT Newswires

Citigroup Adjusts Price Target on Zimmer Biomet to $134 From $140, from 8:23AM ET on Friday May 03, 2024 by MT Newswires

Morgan Stanley Adjusts Price Target on Zimmer Biomet to $130 From $135, from 8:18AM ET on Friday May 03, 2024 by MT Newswires

Jefferies Adjusts Zimmer Biomet Price Target to $135 From $136, from 7:37AM ET on Friday May 03, 2024 by MT Newswires

Citigroup Adjusts Zimmer Biomet Price Target to $134 From $140, from 7:19AM ET on Friday May 03, 2024 by MT Newswires

Morgan Stanley Adjusts Zimmer Biomet Price Target to $130 From $135, from 7:08AM ET on Friday May 03, 2024 by MT Newswires